Search

Your search keyword '"H. Vandekerckhove"' showing total 28 results

Search Constraints

Start Over You searched for: Author "H. Vandekerckhove" Remove constraint Author: "H. Vandekerckhove"
28 results on '"H. Vandekerckhove"'

Search Results

1. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

2. Bruuske syncope in een pashokje

3. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

4. 5PSQ-124 Anticoagulation management within a hospital setting: identifying risk factors affecting patient safety

9. Stenosis of caval connections in orthotopic heart transplantation: an underestimated complication?

12. Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study.

13. Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.

14. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.

15. Feasibility and cost of FH cascade screening in Belgium (BEL-CASCADE) including a novel rapid rule-out strategy.

16. Screening for Fabry Disease in Male Patients With Arrhythmia Requiring a Pacemaker or an Implantable Cardioverter-Defibrillator.

17. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.

19. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials.

20. Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys.

21. Atrial Myxoma With Feeding Vessels From Both the Right and Left Coronary Arteries: A Rare Finding During Coronary Angiography.

22. Assessment of variables affecting late left ventricular flow propagation velocity.

23. Cytomegalovirus myocarditis in an immunocompetent patient.

24. Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why?

25. Assessment of the tilting properties of the human mitral valve during three main phases of the heart cycle: an echocardiographic study.

26. Myocardial oxygen demands of job activities in post-myocardial infarct patients.

Catalog

Books, media, physical & digital resources